Vitract

Transforming mental health through the gut

Vitract is a sustainability company in Mississauga, Canada, founded in 2022. It has raised $1.1M across 1 round, most recently a $1.1M Seed in April 2022.

Headquarters
Mississauga
Employees
1–10
Founded
2022
Business Model
B2C
Total Funding
$1.1M
Last Round
$1.1M SeedApr 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 1 funding round and 5 investors for this company. to use credits for reveals, or explore the API.

About

Vitract (Techstars NYC '22) is a health technology company that reverse chronic illnesses strongly tied to the gut microbiome, including digestive, metabolic, and mental illnesses. The company offers highly-personalized holistic treatment plans that address underlying causes rather than symptoms, using in-depth lab testing combined with personalized dietary and lifestyle recommendations. Vitract's approach is grounded in the premise that a healthy gut microbiome is the center of whole-body homeostasis, and it works to fix gut microbial imbalances to improve patient outcomes.

Funding History

Data from Indexed.vcUpdated
SeedSeed RoundApr 2022
$1.1M

Investors

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

  • Cloud/Infrastructure ×2

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Companies in related industries

COMPASS PathwaysIPO

COMPASS Pathways is dedicated to accelerating patient access to evidence-based innovation in ment...

London, United Kingdom51–200Biotech
Venture RoundTotal funding$997.0MFeb 2026
Solugen

Solugen manufactures lower-carbon specialty chemicals using its Bioforge platform, combining enzy...

Houston, United States51–200Sustainability
Venture RoundTotal funding$695.7MMar 2026
Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Biotech
Series ATotal funding$3.0BJan 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vitract on Indexed.vc
<a href="https://indexed.vc/companies/vitract"><img src="https://indexed.vc/api/badge/company/vitract" alt="Vitract on Indexed.vc" width="260" height="76" /></a>